In the ceRNA network, miR-103a-3p is elevated in the urine of patients with diabetes mellitus and upregulated in the plasma of patients with hypertension [24, 25], and modulated SNRK/NF-κB/p65 signaling promotingangiotensin II–induced renal inflammation and fibrosis [26]. The gene discussed is SNRK; the disease is hypertensive disorder.